The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| SEM | -21.26% | +19.8% | +3.68% | +242% |
| S&P | +15.06% | +95.03% | +14.29% | +545% |
Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offer physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.
Critical care hospitalizations were up during the quarter, for obvious reasons.
Looking for hospital stocks to buy? Here's why HCA Healthcare, Select Medical Holdings, and Tenet Healthcare rank at the top.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $1.34B | -23.9% |
| Gross Profit | $120.60M | -41.9% |
| Gross Margin | 9.00% | -2.8% |
| Market Cap | $1.95B | -20.5% |
| Market Cap / Employee | $0.04M | 0.0% |
| Employees | 44.1K | -19.2% |
| Net Income | $57.06M | -37.6% |
| EBITDA | $119.79M | -43.5% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $52.35M | -52.9% |
| Accounts Receivable | $909.46M | -15.6% |
| Inventory | 0 | 0.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.66B | -43.3% |
| Short Term Debt | $218.98M | -31.1% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | 1.85% | -1.5% |
| Return On Invested Capital | 3.36% | -0.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | $45.61M | -79.5% |
| Operating Free Cash Flow | $110.29M | -60.3% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Earnings | 16.27 | 11.37 | 12.43 | 14.23 | -15.15% |
| Price to Book | 1.72 | 1.27 | 1.28 | 1.13 | -36.09% |
| Price to Sales | 0.62 | 0.37 | 0.35 | 0.33 | -47.58% |
| Price to Tangible Book Value | -1.01 | -1.25 | -2.86 | -2.72 | 178.04% |
| Price to Free Cash Flow TTM | 15.10 | 10.54 | 7.11 | 14.28 | -26.39% |
| Enterprise Value to EBITDA | 47.76 | 94.22 | 35.31 | 42.31 | -6.20% |
| Free Cash Flow Yield | 6.6% | 9.5% | 14.1% | 7.0% | 35.85% |
| Return on Equity | 16.7% | 13.3% | 10.4% | 8.2% | -58.07% |
| Total Debt | $4.57B | $2.70B | $2.79B | $2.88B | -42.50% |
SEM earnings call for the period ending June 30, 2022.
SEM earnings call for the period ending March 31, 2022.
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
